ArticleCancer2025
Erratum to "Incorporation of alemtuzumab into frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study".
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.